Based on our experiments we have proposed inhibitors that interacts to the druggable site of the protein. Furthermore, we have also suggested druggable site on the fibril interface that has higher changes of inhibitor binding. The research will assist in finding effective treatments for this illness and will help mitigate the healthcare problem caused by this disease.